MOG and myeloid sarcoma: However, it is currently unclear which disease should be mimicked with this model, as it was shown that MS does not harbor anti-MOG autoantibodies and MOGAD probably has a complement-activating component driving lesion formation (13, 35) although the extent of complement involvement in human pathology is under debate.